Malignant Pharyngeal Neoplasm — Trials

Malignant Pharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,255 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 222
Ph III recruiting: 64
Growth YoY: +6.1%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 30.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 101–123 of 123 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06009861	Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)	active not recruiting	Phase 2	110	Peking University Hospital of StomatologyOTHER	1	Jun 6, 2025	clinicaltrials
NCT04974398	A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma	active not recruiting	Phase 3	296	AkesoINDUSTRY	5	Apr 13, 2025	clinicaltrials